In a country like India, where we are facing a far heavier burden of genetic disorders, the transformation to data-driven ...

Despite affecting every woman, menopause remains one of the most under-discussed, under-researched, and under-treated phases ...

A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...

WHO stated that the work to understand the origins of SARS-CoV-2 remains unfinished and welcomes any further evidence on the ...

Genomic testing demand in India rises rapidly with deeper reach into Tier 2 and 3 cities, driven by affordability, awareness, ...

Kindly share this postCybercrime has emerged as a dominant security concern across Africa, with more than 30 percent of all reported crimes in Western and Eastern regions linked to cyber activity, ...